ES2188605T3 - Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina. - Google Patents

Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina.

Info

Publication number
ES2188605T3
ES2188605T3 ES94306917T ES94306917T ES2188605T3 ES 2188605 T3 ES2188605 T3 ES 2188605T3 ES 94306917 T ES94306917 T ES 94306917T ES 94306917 T ES94306917 T ES 94306917T ES 2188605 T3 ES2188605 T3 ES 2188605T3
Authority
ES
Spain
Prior art keywords
disease
vaccine against
viric
poxviral
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94306917T
Other languages
English (en)
Inventor
Terri Wasmoen
Lloyd Chavez
Hsien-Jue Chu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of ES2188605T3 publication Critical patent/ES2188605T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION EXPONE UN POXVIRUS RECOMBINANTE DE MAPACHE UTIL COMO VACUNA CONTRA LA ENFERMEDAD DEL VIRUS DE PERITONITIS INFECCIOSA FELINA. EL POXVIRUS RECOMBINANTE DE MAPACHE TIENE AL MENOS UN GEN INTERNO QUE COMPRENDE UNA SECUENCIA DE ADN QUE CODIFICA UN MIEMBRO ELEGIDO DEL GRUPO CONSISTENTE EN LAS PROTEINAS NUCLEOCAPSIDE (N) Y LA TRANSMEMBRANA (M/E1) DEL VIRUS DE PERITONITIS INFECCIOSA FELINA (FIPV).
ES94306917T 1993-09-22 1994-09-21 Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina. Expired - Lifetime ES2188605T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12551693A 1993-09-22 1993-09-22

Publications (1)

Publication Number Publication Date
ES2188605T3 true ES2188605T3 (es) 2003-07-01

Family

ID=22420074

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94306917T Expired - Lifetime ES2188605T3 (es) 1993-09-22 1994-09-21 Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina.

Country Status (13)

Country Link
US (2) US5770211A (es)
EP (1) EP0652287B1 (es)
JP (2) JPH07184662A (es)
AT (1) ATE233821T1 (es)
AU (1) AU680531B2 (es)
CA (1) CA2132374C (es)
DE (1) DE69432207T2 (es)
DK (1) DK0652287T3 (es)
ES (1) ES2188605T3 (es)
NZ (1) NZ264518A (es)
PT (1) PT652287E (es)
SG (1) SG55095A1 (es)
TW (1) TW377373B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202225B1 (en) * 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US6241989B1 (en) * 1991-07-09 2001-06-05 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
US7087234B1 (en) * 1991-07-09 2006-08-08 Cornell Research Foundation, Inc. Recombinant multivalent viral vaccine
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
FR2751223B1 (fr) 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
AU5597998A (en) * 1996-12-04 1998-06-29 Heska Corporation Recombinant plague vaccine
AU7350798A (en) * 1997-04-29 1998-11-24 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
US6106841A (en) * 1998-02-04 2000-08-22 Heska Corporation Delivery method for recombinant raccoon poxvirus
US20050161884A1 (en) * 1998-02-17 2005-07-28 Au-Yeung Chi F. Method of and apparatus for playing a card game
ES2367245T3 (es) * 1998-05-01 2011-10-31 Schering-Plough Ltd. Virus recombinante que expresa adn foráneo que condifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
US7279168B2 (en) 1998-05-01 2007-10-09 Texas A & M University System Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
PT1370668E (pt) 2001-03-08 2006-06-30 Akzo Nobel Nv Vacinas de vector baseadas em leporipox
US7255986B2 (en) * 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
WO2008150404A1 (en) * 2007-05-30 2008-12-11 Wyeth Raccoon poxvirus expressing genes of feline antigens

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8107025A1 (es) * 1978-11-30 1980-12-16 Wellcome Found Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
JPS63123385A (ja) * 1986-09-05 1988-05-27 デュファル・インテルナチオナル・レセールフ・ベー・ヴェー 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン
US5266313A (en) * 1987-02-03 1993-11-30 The United States Of America As Represented By The Department Of Health And Human Services Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms
IL87911A0 (en) * 1987-10-01 1989-03-31 Norden Lab Inc Vaccine for protection of cats against feline infectious peritonitis
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2011025A1 (en) * 1989-03-01 1990-09-01 Terry R. Beardsley Feline infectious peritonitis vaccine
HUT54733A (en) * 1989-07-12 1991-03-28 Duphar Int Res Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
NZ240558A (en) * 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
WO1993001284A1 (en) * 1991-07-09 1993-01-21 Cornell Research Foundation, Inc. Recombinant viral vaccine

Also Published As

Publication number Publication date
US5770211A (en) 1998-06-23
JP2005336206A (ja) 2005-12-08
SG55095A1 (en) 1998-12-21
NZ264518A (en) 1996-06-25
DK0652287T3 (da) 2003-04-07
CA2132374A1 (en) 1995-03-23
ATE233821T1 (de) 2003-03-15
AU680531B2 (en) 1997-07-31
EP0652287A2 (en) 1995-05-10
CA2132374C (en) 2005-05-17
EP0652287B1 (en) 2003-03-05
JPH07184662A (ja) 1995-07-25
DE69432207D1 (de) 2003-04-10
AU7411694A (en) 1995-04-06
US5656275A (en) 1997-08-12
PT652287E (pt) 2003-06-30
DE69432207T2 (de) 2003-11-13
EP0652287A3 (en) 1997-06-11
TW377373B (en) 1999-12-21

Similar Documents

Publication Publication Date Title
ES2188605T3 (es) Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina.
AR042378A2 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
EE05138B1 (et) Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
AR003135A1 (es) Baculovirus recombinante, una vacuna que los contiene, y el uso del mismo para preparar una vacuna util para evitar o disminuir la enfermedad causada porvirus de inmunodeficiencia felina.
ES2066782T3 (es) Tratamiento de infecciones virales humanas mediante arn bicatenario combinado con inhibidores virales.
DE50214416D1 (de) Vermehrung von viren in zellkultur
DK1526175T3 (da) Coronavirus, nucleinsyre, protein og fremgangsmåde til at skabe vaccine, lægemidler og diagnostika
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
MX9202512A (es) Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.
MXPA03000061A (es) Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos.
DE69936337D1 (de) Verfahren zur entwicklung von einem hiv impfstoff
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
BR9508645A (pt) Vacina da peritonite infecciosa felina
DE50304603D1 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
FR2607518B1 (fr) Vecteur viral et adn recombinant codant pour la proteine p25 du virus agent causal du s.i.d.a., culture cellulaire infectee, proteine obtenue, vaccin et anticorps obtenus
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS
DE69021879D1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.
TH31605A (th) รีคอมบิแนนท์แรคคูนพอกซ์ไวรัสและการใช้มันต่อการติดเชื้อไวรัสก่อโรคภูมิพร่องในแมว
RU94002006A (ru) Штамм культуры клеток человека нтн1 27 - продуцент вируса иммунодефицита человека (вич)